SYSTEMATIC REVIEW
Accepted on 18 Jul 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Interplay of Gut Microbiome, Insulin Resistance, and Diabetes
doi 10.3389/fmed.2025.1618275
- 106 views
- Frontiers in Medicine
- Hepatobiliary Diseases
- Research Topics
- The Gut-Liver Axis in MASLD: Microbiome, Metabolism, Disease Progression and Therapeutic Pathways
The Gut-Liver Axis in MASLD: Microbiome, Metabolism, Disease Progression and Therapeutic Pathways
32
Total downloads
1,027
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.